drugset / Trial / NCT04024163
Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease
NaSingle-groupOpen-labelTreatment
Summary
This study evaluate the efficacy and safety of benznidazole in the treatment of chronic indeterminate Chagas disease in children. All subjects will receive benznidazole and results will be compared to historically to a placebo arm.
Timeline
- Start
- 2019-09-19
- Primary completion
- 2027-08-30
- Completion
- 2028-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Benznidazole | Small molecule | 12.5 mg | Oral |
| Subject | Benznidazole | Small molecule | 100 mg | Oral |